{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:00:02Z","timestamp":1792144802551,"version":"4.4.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","award":["13OI106"],"award-info":[{"award-number":["13OI106"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12882-017-0560-3","type":"journal-article","created":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T07:46:08Z","timestamp":1493711168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Phosphate binders affect vitamin K concentration by undesired binding, an in vitro study"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4012-8346","authenticated-orcid":false,"given":"A.","family":"Neradova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. P.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Hubeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. J.","family":"Schurgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G.","family":"Vervloet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,2]]},"reference":[{"key":"560_CR1","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/S0140-6736(12)61272-0","volume":"380","author":"BK Mahmoodi","year":"2012","unstructured":"Mahmoodi BK, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet. 2012;380:1649\u201361.","journal-title":"Lancet"},{"key":"560_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","volume":"116","author":"EL Schiffrin","year":"2007","unstructured":"Schiffrin EL, Lipman JF, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007;116:85\u201397.","journal-title":"Circulation"},{"key":"560_CR3","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.2215\/CJN.02190507","volume":"2","author":"MK Sigrist","year":"2007","unstructured":"Sigrist MK, Taal MW, Bungay P, McIntyre CW. Progressive vascular calcification over 2\u00a0years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol. 2007;2:1241\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"key":"560_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.atherosclerosis.2016.03.034","volume":"250","author":"A Bellasi","year":"2016","unstructured":"Bellasi A, Ferramosca E, Ratti C, et al. The density of calcified palques and the volume of calcium predict mortality in hemodialysis patients. Atherosclerosis. 2016;250:166\u201371.","journal-title":"Atherosclerosis"},{"key":"560_CR5","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","volume":"342","author":"WG Goodman","year":"2000","unstructured":"Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342:1478\u201383.","journal-title":"N Engl J Med"},{"issue":"5","key":"560_CR6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1053\/j.ajkd.2016.05.015","volume":"68","author":"SC Palmer","year":"2016","unstructured":"Palmer SC, Gardner S, Tonelli M, et al. Phosphate-binding agents in adults with CKD: a network meta-analysis of randomized trials. Am J Kidney Dis. 2016;68(5):691\u2013702.","journal-title":"Am J Kidney Dis"},{"key":"560_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/1074248413486355","volume":"18","author":"T Ohtake","year":"2013","unstructured":"Ohtake T, Kobayashi S, Oka M, et al. Lanthanum carbonate delays progression of coronary artery calcification compared with calcium-based phosphate binders in patients on hemodialysis: a pilot study. J Cardiovasc Pharmacol Ther. 2013;18:439\u201346.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"560_CR8","first-page":"134","volume":"13","author":"P Raggi","year":"2004","unstructured":"Raggi P, Bommer J, Chertow GM. Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer. J Heart Valve Dis. 2004;13:134\u201341.","journal-title":"J Heart Valve Dis"},{"key":"560_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","volume":"62","author":"GM Chertow","year":"2002","unstructured":"Chertow GM, Burke SK, Raggi P, Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002;62:245\u201352.","journal-title":"Kidney Int"},{"key":"560_CR10","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1681\/ASN.2012030223","volume":"23","author":"GA Block","year":"2012","unstructured":"Block GA, Wheeler DC, Persky MS, et al. Effects of phosphate binders in moderate CKD. J Am Soc Nephrol. 2012;23:1407\u201315.","journal-title":"J Am Soc Nephrol"},{"key":"560_CR11","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/ki.2012.403","volume":"83","author":"KM Hill","year":"2013","unstructured":"Hill KM, Martin BR, Wastney ME, et al. Oral calcium carbonate affects calcium but not phosphorus balance in stage 3\u20134 chronic kidney disease. Kidney Int. 2013;83:959\u201366.","journal-title":"Kidney Int"},{"key":"560_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/ndt\/gfv021","volume":"30","author":"C Zoccali","year":"2015","unstructured":"Zoccali C, London G. Con: vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease. Nephrol Dial Transplant. 2015;30:352\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"560_CR13","doi-asserted-by":"publisher","first-page":"568","DOI":"10.2215\/CJN.07081009","volume":"5","author":"LJ Schurgers","year":"2010","unstructured":"Schurgers LJ, Barreto DV, Barreto FC, et al. The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clin J Am Soc Nephrol. 2010;5:568\u201375.","journal-title":"Clin J Am Soc Nephrol"},{"key":"560_CR14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1053\/j.ajkd.2011.10.041","volume":"59","author":"R Westenfeld","year":"2012","unstructured":"Westenfeld R, Krueger T, Schlieper G, et al. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis. 2012;59:186\u201395.","journal-title":"Am J Kidney Dis"},{"key":"560_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.molmed.2012.12.008","volume":"19","author":"LJ Schurgers","year":"2013","unstructured":"Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013;19:217\u201326.","journal-title":"Trends Mol Med"},{"issue":"5","key":"560_CR16","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1093\/ndt\/gfq598","volume":"26","author":"D Pierce","year":"2011","unstructured":"Pierce D, Hossack S, Poole L, et al. The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol. Nephrol Dial Transplant. 2011;26(5):1615\u201321.","journal-title":"Nephrol Dial Transplant"},{"key":"560_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5414\/CNP73030","volume":"73","author":"K Takagi","year":"2010","unstructured":"Takagi K, Masuda K, Yamazaki M, et al. Metal ion and vitamin adsorption profiles of phosphate binder ion-exchange resins. Clin Nephrol. 2010;73:30\u20135.","journal-title":"Clin Nephrol"},{"key":"560_CR18","first-page":"298","volume":"30","author":"LJ Schurgers","year":"2000","unstructured":"Schurgers LJ, Vermeer C. Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations. Haemostasis. 2000;30:298\u2013307.","journal-title":"Haemostasis"},{"key":"560_CR19","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1002\/jps.20956","volume":"96","author":"V Autissier","year":"2007","unstructured":"Autissier V, Damment SJP, Henderson A. Relative in vitro efficacy of phosphate binders lanthanum carbonate and sevelamer hydrochloride. J Pharm Sci. 2007;96:2818\u201327.","journal-title":"J Pharm Sci"},{"key":"560_CR20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1053\/j.ajkd.2013.03.023","volume":"62","author":"B Iorio Di","year":"2013","unstructured":"Di Iorio B, Molony D, Bell C, et al. Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial. Am J Kidney Dis. 2013;62:771\u20138.","journal-title":"Am J Kidney Dis"},{"key":"560_CR21","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2215\/CJN.03820411","volume":"7","author":"B Iorio Di","year":"2012","unstructured":"Di Iorio B, Bellasi A, Russo D, INDEPENDENT Study Investigators. Mortality in kidney disease patients treated with phosphate binders: a randomized study. Clin J Am Soc Nephrol. 2012;7:487\u201393.","journal-title":"Clin J Am Soc Nephrol"},{"key":"560_CR22","first-page":"E124","volume":"233","author":"E Rim","year":"1977","unstructured":"Rim E, Ruble Jr PE. Vitamin K2 colonic and ileal in vivo absorption: bile, fatty acids, and pH effects on transport. Am J Physiol. 1977;233:E124\u20139.","journal-title":"Am J Physiol"},{"key":"560_CR23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1160\/TH08-02-0087","volume":"100","author":"LJ Schurgers","year":"2008","unstructured":"Schurgers LJ, Cranenburg EC, Vermeer C. Matrix Gla-protein: the calcification inhibitor in need of vitamin K. Thromb Haemost. 2008;100:593\u2013603.","journal-title":"Thromb Haemost"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0560-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T16:39:10Z","timestamp":1569170350000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-017-0560-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,2]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["560"],"URL":"https:\/\/doi.org\/10.1186\/s12882-017-0560-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,2]]},"article-number":"149"}}